Related Experiment Video
Updated: Nov 6, 2025

10:37
Author Spotlight: Decellularization-Based Quantification of Skeletal Muscle Fatty Infiltration
Published on: June 9, 2023
3.6K
Intramuscular fatty infiltration and physical function in controlled acromegaly.
Luciana Martel-Duguech1,2,3, Jorge Alonso-Pérez3,4, Helena Bascuñana5
1IIB-Sant Pau and Department of Endocrinology/Medicine, Hospital Sant Pau, Barcelona, Spain.
European Journal of Endocrinology
|May 5, 2021
Summary
Patients with acromegaly have increased thigh muscle fat, leading to muscle dysfunction and poorer performance in mobility tests, even after disease control. Further research is needed to understand these mechanisms.
Area of Science:
- Endocrinology
- Musculoskeletal Health
- Medical Imaging
Background:
- Acromegaly patients often experience persistent musculoskeletal symptoms.
- Increased intramuscular (i.m.) fat fraction is linked to muscle dysfunction in various conditions.
Purpose of the Study:
- To quantify thigh muscle fat fraction in controlled acromegaly patients.
- To investigate the association between fat fraction and muscle dysfunction.
Main Methods:
- Cross-sectional study comparing 36 acromegaly patients and 36 controls.
- MRI 2-point Dixon sequence used to assess thigh muscle fat fraction.
- Muscle function assessed via gait speed, timed up and go, 30-s chair stand, and grip strength tests.
Main Results:
- Acromegaly patients exhibited higher thigh i.m. fat fraction in multiple muscle compartments compared to controls.
- Patients demonstrated reduced performance in gait speed, chair stand, and timed up and go tests.
- Increased fat fraction correlated with poorer timed up and go performance, predicting outcomes independently of muscle size and disease markers.
Conclusions:
- Controlled acromegaly is associated with elevated thigh i.m. fatty infiltration.
- This fatty infiltration is linked to demonstrable muscle dysfunction.
- Further investigation is required to clarify the underlying mechanisms of this relationship.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
2.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.3K
Myasthenia Gravis: Diagnostic Tests
1.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K

